УДК:616.831/.832-009.7-02:[616.988.7:578.834.1](048.8)

Метароботи  –  висвітлитивиObjective ‒to highlight the high probability and features of neurological complications in patients with COVID-19 pneumonia.Materials  and  methods.  A  retrospective  cohort  study  was  done  of  57  patients  with  COVID-19 pneumonia who were treated at the COVID-location of the Department of Vascular and Minimally Invasive Neurosurgery and Neurology of the Clinical Emergency Hospital of Lviv in the period from June 29 to September 28, 2020 (91 day).Results. Out of the 57 patients 14 (24.6 %) were selected by prospective analysis that had a clear association between COVID-19 pneumonia and neurological complications. Neurolo-gical complications of COVID-19 were manifested as ischemic stroke in 57.1 % of patients, encephalopathy with convulsions and without seizures ‒ in 35.7 %, polyneuropathy with tet-raparesis, secondary purulent-inflammatory lesions of the spine ‒ in 7.2 %. Neurological com-plications occurred on average (20. 4 ± 6.1) days after the onset of the disease.Conclusions. Lesions of the spine and structures in the spinal canal after coronavirus infec-tion had a significant spread along the axis of the spine and severe course. The largest (57.1 %) was  the  proportion  of  ischemic  stroke  in  the  structure  of  neurological  complications  of  COVID-19, which indicated the severity of the coronavirus infection and its aggressive effect on the nervous system. The effectiveness of treatment of COVID-19 neurological complica-tions  depends  on  the  urgency  of  hospitalization  of  patients,  as  evidenced  by  the  correlation  between favorable treatment outcomes and the time from disease onst to admission to either therapeutic (r = + 0.37) or neurological department (r = +0.32).